|
|
|
市場調查報告書
藥品業界用奈米封裝 : 全球技術・産業・市場分析
NANO-ENABLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY - A GLOBAL TECHNOLOGY, INDUSTRY AND MARKET ANALYSIS
|
藥品業界用奈米封裝 : 全球技術・産業・市場分析 是由出版商Innovative Research and Products (iRAP), Inc.在2010年03月所出版的。
這份英文市場調查報告書包含93 Pages 價格從美金2950起跳。
藥品業界的封裝在這10年有重大變化。除了隔絕水分與光、氧氣的保護機能，現在的封裝設計在藥物於體內輸送及擴散的程序中扮演了重要的角色，對藥劑安全性相當有貢獻。
本報告書為增進對醫藥品業界的奈米封裝現狀之理解，包含有對市場機會與參加企業、所需技術與智慧財產動向之統整等內容、概述如下。
導論
總綱
產業概要
技術概要
- 封裝技術
- 動態封裝
- 高氧化物的使用
- 水分管理
- 為了藥劑處方的保護
- 適當的封裝方案之取得
- 智慧封裝
- 防止偽裝
- 藥劑適合性
- 封裝應用
- 封裝材料
- 將來動向
市場分析
專利與專利分析
企業簡介
圖表
Abstract
Packaging in the pharmaceutical industry has gone through major changes in the
past decade. The advent of new drug delivery systems and the development of
new biochemical compounds have resulted in a need not only for enhanced
protection against factors such as moisture, light, oxygen and mechanical
forces, but also for packaging forms to play a more integral role in the drug
delivery process. Packaging design today provides stability and shelf life to
the drug and the delivery system, which becomes fundamental to the safety,
convenience and compliance of drug use.
Nanotechnology, the science of very small materials, is poised to have a big
impact in pharmaceutical packaging. Basic categories of nanotechnology
applications and functionalities appear in development of pharmaceutical (or
pharma) packaging in terms of enhancement of plastic materials' barriers;
incorporation of active components that can deliver functional attributes
beyond those of conventional active packaging; and sensing and signaling of
relevant information.
study goal and objectives
The study is intended to benefit existing manufacturers of pharmaceuticals who
seek to expand market opportunities. It also can serve as a reference for
pharma packaging industry players who would like to expand to nano-enabled
technologies for drug packaging. This study also provides the most complete
accounting of nano-enabled packaging of pharmaceutical products in various
markets around the globe.
The main objective of this report is to understand the current state of
nano-enabled packaging in the pharmaceutical industry, market opportunities,
the companies involved, technologies being pursued and intellectual property
(IP) trends.
This study covers various aspects of nano-enabled packaging, providing data
about the size and growth of application segments, industry trends, new
developments including a detailed patent analysis, and company profiles.
Another goal of this report is to provide a detailed and comprehensive
multi-client study of the market in North America, Europe, Asia Pacific and
the rest of the world for nano-enabled packaging, as well as potential
business opportunities emerging in the future.
The study objectives include thorough coverage of the underlying economic
issues driving the nano-enabled packaging business, as well as assessments of
new advanced nano-enabled packaging that are being developed. Particular
attention was paid to providing realistic market data and forecasts for the
nano-enabled packaging industry segments. This study provides the most
thorough and up-to-date assessment that can be found anywhere on the subject.
The study also provides extensive quantification of the many important facets
of market developments in nano-enabled packaging all over the world.
Ultimately, the study contributes to the determination of the kinds of
strategic responses that can be adopted by companies hoping to compete in this
dynamic market.
REASONS FOR DOING THE STUDY
In the pharmaceutical industry, there is an ever growing emphasis on security,
as well as on patient convenience and greater automation, without compromising
quality or safety standards. Increasing importance has been placed on the role
that packaging plays in establishing brand preference.
The role of packaging in pharmaceuticals has taken an incremental leap forward
in terms of its critical importance as an integral part of the product. New
packaging solutions will focus more on drug safety by controlling microbial
growth, delaying oxidation, improving tamper visibility and enhancing
convenience. Therefore, iRAP felt a need to do a detailed market update and
analysis for this industry.
Contributions of the study
This study provides the most complete accounting of the nano-enabled pharma
packaging market growth in North America, Europe, Asia Pacific and the rest of
the world currently available in a multi-client format. It provides the most
thorough and up-to-date assessment that can be found anywhere on the subject
and includes extensive quantification of the many important facets of market
developments in various markets for nano-enabled pharma packaging. This
quantification, in turn, contributes to the determination of strategic
responses that suppliers may adopt in order to compete in these dynamic
markets. Audiences for this study include marketing executives, business unit
managers and other decision makers in the pharma packaging companies, as well
as in companies peripheral to this business.
SCOPE AND FORMAT
The market data contained in this report quantifies opportunities for
nano-enabled packaging technologies, nanomaterials used for packaging, and
technology applications. In addition to product types, it also covers the
merits and future prospects of the nano-enabled pharma packaging business. It
also covers in detail the economic and regulatory issues regarded by many as
critical to the industry' s current state of change. The report provides a
review of the nanotechnologies involved in the pharma packaging industry, its
structure, and the companies involved in providing these packaged products.
TO WHOM THE STUDY CATERS
The report provides the most thorough and up-to-date assessment that can be
found anywhere on the subject. The study is intended to benefit current pharma
packaging producers and users as well as developers of new technologies in
this area. Specifically, the report would be of great use to:
- producers and suppliers of pharma packaging;
- suppliers of pharma packaging materials;
- resin supplier;
- producers and suppliers of nanoparticles;
- users of pharma packaging;
- universities and research institutions involved in research in the pharma
packaging area; and investors and venture capitalists interested in new
technology areas.
REPORT SUMMARY
Packaging in the pharmaceutical industry has gone through major changes in the
past decade. The advent of new drug delivery systems and the development of
new biochemical compounds have resulted in a need not only for enhanced
protection against factors such as moisture, light, oxygen and mechanical
forces, but also for packaging forms to play a more integral role in the drug
delivery process.
Nanotechnology is poised to have a big impact in pharmaceutical packaging and
will enable it to bring innovative and new generation packaging solutions to
market. The addition of certain nanoparticles into shaped objects and films
has been shown to render them light, fire-resistant and stronger in terms of
mechanical and thermal performance, as well as less permeable to gases. Thus,
it is possible to make new packaging solutions that focus more on drug safety
by controlling microbial growth and delaying oxidation as well as improving
tamper visibility and anti-counterfeiting.
As nanotechnology meets the new demands of pharma packaging, there are
opportunities for tremendous growth in next few years. To clearly understand
the landscape and undercurrents, the nano-enabled packaging for pharma
industry has been segmented by:
- technology - active and smart packaging;
- pharma packaging applications - blisters, containers, bottles, pouches,
syringes etc.; and
- market regions - namely, North America, Latin America, Europe (including
Russia), Asia Pacific and China.
The total market for nano-enabled packaging for pharma is $3.8 billion in
2009, which is expected to grow to $8.1 billion by 2014, at a compound annual
growth rate (CAGR) of 16.48% from 2009 to 2014.
Other major findings of this report are:
- The U.S. and Europe will remain the largest consumers of pharmaceutical
packaging, as their advanced drug-producing sectors introduce new therapies
with specialized packaging needs.
- The North America market for nano-enabled packaging in pharma will grow
from $1.08 billion in 2008 to $2.03 billion by 2014. The European market will
grow from $1.15 billion in 2008 to $1.46 billion in 2014.
- Japan continues to have the major share of the Asia Pacific market (65%),
but its share is expected to decrease as India evolves into a fast-growing
pharmaceutical packaging market as drug-producing sectors are upgraded and
diversified, especially in the area of generic drugs.
China' s growth opportunities will be among the strongest, based on rapidly
expanding pharmaceutical manufacturing capabilities there and the phasing-in
of a government program designed to upgrade the quality and integrity of
nationally produced medicines.
Table of Contents
INTRODUCTION
- STUDY GOAL AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- CONTRIBUTIONS OF THE STUDY
- SCOPE AND FORMAT
- METHODOLOGY
- INFORMATION SOURCES
- WHOM THE STUDY CATERS TO
- AUTHOR' S CREDENTIALS
EXECUTIVE SUMMARY
- SUMMARY TABLE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY,
2008, 2009 AND 2014 ($ BILLIONS)
- SUMMARY FIGURE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY,
2009 AND 2014
INDUSTRY OVERVIEW
- INDUSTRY PLAYERS
- TABLE 1 COMPANIES IN NANO ENABLED PACKAGING FOR PHARMA
- MARKET SEGMENTS
- MARKET BY APPLICATION TYPES
- MARKET BY APPLICATION TYPES (CONTINUED)
- TABLE 2 MARKET FOR NANO ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE,
2008, 2009 AND 2014 ($ BILLIONS)
- FIGURE 1 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE,
2009 AND 2014
- MARKET BY TECHNOLOGY
- TABLE 3 MARKET FOR NANO ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008,
2009 AND 2014 ($ BILLIONS)
- FIGURE 2 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009
AND 2014
- MARKET BY REGION
- MARKET BY REGION (CONTINUED)
- TABLE 4 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY REGIONS, 2008,
2009 AND 2014
- FIGURE 3 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY REGIONS, 2009 AND
2014
- REGULATORY ISSUES
TECHNOLOGY OVERVIEW
- PACKAGING TECHNOLOGY
- ACTIVE PACKAGING
- HANDLING HIGHLY OXIDATIVE COMPOUNDS
- HANDLING HIGHLY OXIDATIVE COMPOUNDS
- (CONTINUED)
- MOISTURE CONTROL
- PROTECTION FOR DRUG FORMULATIONS
- PROTECTION FOR DRUG FORMULATIONS
- (CONTINUED)
- GETTING THE RIGHT PACKAGING SOLUTION
- SMART PACKAGING
- TAMPERING AND COUNTERFEITING
- TAMPERING AND COUNTERFEITING (CONTINUED)
- DRUG COMPLIANCE
- DRUG COMPLIANCE (CONTINUED)
- DRUG COMPLIANCE (CONTINUED)
- TABLE 5 NEW COMPLIANCE PRODUCT INTRODUCTIONS
- PACKAGING APPLICATION TYPES
- BLISTER PACKS
- BLISTER PACKS (CONTINUED)
- CONTAINERS (INHALERS AND SYRINGES)
- PLASTIC BOTTLES
- POUCHES AND STRIPS
- ACCESSORIES AND CLOSURES
- PACKAGING MATERIAL TYPES
- SECURED ALUMINUM FOIL
- NANO-ENABLED THIN FILMS
- NANO-ENABLED THIN FILMS (CONTINUED)
- COATINGS
- FUTURE TRENDS
- FUTURE TRENDS (CONTINUED)
MARKET ANALYSIS
- GLOBAL INDUSTRY
- MERGERS AND ACQUISITIONS
- TABLE 6 PACKAGING-RELATED MERGERS AND ACQUISITIONS IN THE PHARMA INDUSTRY
(2004-2009)
- TABLE 6 PACKAGING-RELATED MERGERS AND ACQUISITIONS IN THE PHARMA INDUSTRY,
2004-2009 (CONTINUED)
- GLOBAL MARKETS
- NORTH AMERICA
- TABLE 7 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
- FIGURE 4 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- TABLE 8 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014 ($
- BILLIONS)
- FIGURE 5 NORTH AMERICA MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- LATIN AMERICA
- TABLE 9 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
- FIGURE 6 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- TABLE 10 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014 ($
- BILLIONS)
- FIGURE 7 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- EUROPE
- TABLE 11 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILIONS)
- FIGURE 8 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- TABLE 12 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014
- FIGURE 9 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- ASIA-PACIFIC
- TABLE 13 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
- FIGURE 10 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- TABLE 14 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
- FIGURE 11 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- CHINA
- TABLE 15 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
- FIGURE 12 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- TABLE 16 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
- FIGURE 13 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
PATENTS AND PATENT ANALYSIS
- LIST OF PATENTS
- HIGH STABILITY PACKAGE FOR DENTAL TREATMENT DEVICES
- SORBENT CANISTER WITH BEVELED EDGES
- CHILD-RESISTANT COMPACT FOR BLISTER CARD PRODUCTS
- THREADED CHILD-RESISTANT PACKAGE HAVING LINERLESS
- CLOSURE
- CHILD-RESISTANT ONE-PIECE PUSH AND TURN CLOSURE
- HUMIDITY CONTROL DEVICE
- CLOSURE AND CONTAINER PACKAGE WITH RFID CIRCUIT
- PLASTIC PACKAGING HAVING A MARKER MATERIAL
- CHILD-RESISTANT TAMPER-INDICATING PACKAGE
- POLYACRYLIC FILM FORMING COMPOSITIONS
- CHILD-RESISTANT FLIP-TOP DISPENSING CLOSURE AND PACKAGE
- CLOSURE AND PACKAGE HAVING CHILD-RESISTANT AND NON-CHILD-RESISTANT MODES
OF OPERATION
- CLOSURE AND PACKAGE WITH INDUCTION SEAL AND RFID TAG
- MONITORING OBJECT MOVEMENT
- CHILD-RESISTANT CONTAINER AND CAP
- OXYGEN-ABSORBING COMPOSITIONS AND METHOD
- DEACTIVATING A DATA TAG FOR TAMPER-EVIDENT PACKAGING
- ACID-GAS ABSORBING TABLET AND METHOD OF USE
- PACKAGING AND DELIVERY OF PHARMACEUTICALS AND DRUGS
- RECLOSEABLE BIOSENSOR
- PACKAGING FILM, PACKAGE AND PROCESS FOR ASEPTIC PACKAGING
- METHOD AND PACKAGING FOR PRESSURIZED CONTAINERS
- SORBENT CAPSULE
- OXYGEN-ABSORBING COMPOSITION
- TAMPER-INDICATING BAND ARRESTER
- PRESSED ADSORBENT AND METHOD OF FABRICATION THEREOF
- CHILD-RESISTANT DISPENSER
- INTERACTIVE INFORMATION PACKAGE
- DISPENSING CLOSURE
- SELF-RETAINING ADSORBENT UNIT
- PHARMACEUTICAL KIT FOR OXYGEN-SENSITIVE DRUGS
- OXYGEN SCAVENGING COMPOSITIONS FOR PACKAGING APPLICATIONS
- ONE-HAND OPENING CHILD-RESISTANT BLISTER PACK CONTAINER
- PHARMACEUTICAL KIT FOR OXYGEN-SENSITIVE DDRUGS
- DISPENSING UNIT FOR OXYGEN-SENSITIVE DRUGS
- PATENT ANAYLSIS
- TABLE 17 NUMBER OF U.S. PATENTS GRANTED TO COMPANIES IN THE OXYGEN
SCAVENGING CATEGORY FROM 2004 THROUGH 2008
- FIGURE 14 TOP COMPANIES GRANTED U.S. PATENTS FOR BARRIER PACKAGING IN
PHARMA FROM 2004 THROUGH 2008
COMPANY PROFILES
- AARDEX LTD
- ABR PHARMA
- ALCOA FLEXIBLE PACKAGING
- ALCAN PACKAGING
- ALLPLAS EMBALAGENS, LTDA
- AMCOR FLEXIBLES WINTERBOURNE
- AMERISOURCE BERGEN CORPORATION
- AMPAC PACKAGING, LLC
- ANDERSON PACKAGING INC
- ASTRA ZENECA PLC
- BANG & OLUFSEN MEDICOM
- BILCARE LIMITED
- BOSCH PACKAGING TECHNOLOGY
- BRISTOL-MYERS SQUIBB CO
- BURGOPAK LTD
- CARDINAL HEALTH, INC
- COLBERT PACKAGING
- CSP TECHNOLOGIES, INC
- CRYOPAK INDUSTRIES
- CRYOVAC SEALED AIR CORPORATION
- CURWOOD, INC
- CYPAK AB
- DRAGON INTERNATIONAL GROUP CORP
- ECOBLISS-PHARMA
- GERRESHEIMER
- GLAXOSMITHKLINE PLC
- HONEYWELL INTERNATIONAL INC
- INEOS FILMS INC
- INFORMATION MEDIARY CORPORATION
- KIMBERLY-CLARK HEALTH CARE
- KLOCKNER PENTAPLAST
- MCNEIL CONSUMER HEALTHCARE
- MEADWESTVACO CORPORATION (MWV)
- MENASHA CORPORATION
- MERCK
- MULTISORB TECHNOLOGIES, INC
- NEOPAC
- PACKSHIELD
- PERFECSEAL LTD
- REXAM CLOSURES
- ROCHE DIAGNOSTICS CORPORATION
- SCHOTT NORTH AMERICA, INC
- STORA ENSO
- SUD-CHEMIE AG
- SUPERFOS A/S
- TEKNI-FILMS U.S
- THERMO FISHER SCIENTIFIC INC
- UNITED DRUG PLC
- WYETH CONSUMER HEALTHCARE, INC
LIST OF TABLES
- SUMMARY TABLE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY,
2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 1 COMPANIES IN NANO ENABLED PACKAGING FOR PHARMA
- TABLE 2 MARKET FOR NANO ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE,
2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 3 MARKET FOR NANO ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008,
2009 AND 2014 ($ BILLIONS)
- TABLE 4 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY REGIONS, 2008,
2009 AND 2014
- TABLE 5 NEW COMPLIANCE PRODUCT INTRODUCTIONS
- TABLE 6 PACKAGING-RELATED MERGERS AND ACQUISITIONS IN THE PHARMA INDUSTRY
(2004-2009)
- TABLE 6 PACKAGING-RELATED MERGERS AND ACQUISITIONS IN THE PHARMA INDUSTRY,
2004-2009 (CONTINUED)
- TABLE 7 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 8 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 9 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 10 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 11 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILIONS)
- TABLE 12 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014
- TABLE 13 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 14 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 15 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 16 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
- TABLE 17 NUMBER OF U.S. PATENTS GRANTED TO COMPANIES IN THE OXYGEN
SCAVENGING CATEGORY FROM 2004 THROUGH 2008
LIST OF FIGURES
- SUMMARY FIGURE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY,
2009 AND 2014
- FIGURE 1 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE,
2009 AND 2014
- FIGURE 2 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009
AND 2014
- FIGURE 3 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY REGIONS, 2009 AND
2014
- FIGURE 4 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- FIGURE 5 NORTH AMERICA MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- FIGURE 6 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- FIGURE 7 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- FIGURE 8 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- FIGURE 9 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- FIGURE 10 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- FIGURE 11 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- FIGURE 12 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
TECHNOLOGY, 2009 AND 2014
- FIGURE 13 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY
APPLICATION TYPE, 2009 AND 2014
- FIGURE 14 TOP COMPANIES GRANTED U.S. PATENTS FOR BARRIER PACKAGING IN
PHARMA FROM 2004 THROUGH 2008
醫藥用品的奈米包裝市場在2014年以前的盈利將超過80億美金
2010年04月19日
美國市場調查公司Innovative Research and Products (iRAP), Inc.所發行的報告書「NANO-ENABLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY - A GLOBAL TECHNOLOGY, INDUSTRY AND MARKET ANALYSIS (藥品業界用奈米封裝 : 全球技術・産業・市場分析)」由日商環球訊息有限公司代理販售中。
醫藥用品的奈米包裝市場，於2009年已成長至38億美金。根據iRAP的調查顯示，該市場於2009年至2014年的CAGR將上升至16.5%，並達到81億美金。醫藥用品的包裝在近10年呈現劇烈的變化。目前醫藥品的奈米包裝，確保了藥劑和給藥系統雙方的安全性、壽命，以及藥劑使用的安全性、便利性、適合性等重要要素。另一方面，美國和歐洲是醫藥用品包裝的最大消費地區，而在醫藥用奈米包裝的市場中，中國的成長最受外界期待。
本報告書的主要內容：
- 在醫藥用品的包裝產品中，預充式吸入器和預充式注射器的全球需求，預估將呈現急劇的成長。
- 在單位容量的適合性、臨床試驗、法規遵循、OTC藥以及傳統處方藥的影響下，預估全球發泡包裝的需求將提升。
- 在保護兒童安全對策的實施下，推廣成人容易使用的包裝：含有清楚的標識、防偽功能、以及防止混入毒物的包裝形式，皆進而促進全球醫藥用品包裝市場的成長。
GLOBAL MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014
($ BILLIONS)
GLOBAL MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014
($ BILLIONS)
| | 2008 | 2009 | 2014 | CAGR 2009-2014(%) |
| Active Technology | 3.06 | 3.10 | 5.27 | 11.19 |
| Smart Technology | 0.54 | 0.68 | 2.84 | 33.05 |
| Total | 3.6 | 3.78 | 8.1 | 16.48 |
Source: iRAP, Inc.
|
 |
